All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2026-P-3632
Requests that the FDA to determine that PRALIDOXIME CHLORIDE (AUTOINJECTOR) 600 mg/2 mL intramuscular solution, (NDA 018986) from Meridian Medical Technologies Inc. was not discontinued or withdrawn due to safety or efficacy reasons.
Documents
5
Comments
0
Key Dates
Comment Period OpensApr 2, 2026
Documents
| Type | Title | Status |
|---|---|---|
Supporting Material |
Keywords
CDER
Citizen Petition
Premier Research International LLC
to determine that
PRALIDOXIME CHLORIDE AUTOINJECTOR
600 mg 2 mL intramuscular solution
NDA 018986
from Meridian Medical Technologies Inc
Data from Regulations.gov